与「ProstateCancer」相关的搜索结果

CHHiP vs PROFIT for Localized Prostate Cancer: A Retrospective Dosimetric Comparison of Organs at Risk 🔗 Find the full research article: Moderate hypofractionation for localized prostate cancer has become a standard of care in many radiation therapy centers worldwide. Several fractionation and planning protocols exist, with CHHiP and PROFIT (60 Gy in 20 fractions) being 2 of the most commonly used. We retrospectively compared the doses received by organs at risk (OARs) using these 2 protocols. #ProstateCancer# #RadiationOncology# #RadOnc# #MensHealthMonth# #MHM26# #CaseStudy# #RadOncEd# #MedEd#

Genomic classifiers and AI for personalizing #ProstateCancer# radiation therapy. @drjefstathiou @MassGenBrigham joins @neerajaiims @huntsmancancer to discuss the use of genomic classifiers and AI-based tools in personalizing radiation therapy for prostate cancer. #WatchNow# on UroToday > #APCCC26# @Decipher_VCYT @APCCC_Lugano @arteraAI

Introducing #APCCC26# Live from Lugano🇨🇭Brought to you from APCCC together with @OncoAlert 🚨 Triplet vs Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer | APCCC 2026 Expert Discussion Join Dr. Jones, Dr. Rathkopf, and Dr. Fizazi for an expert discussion on one of the most rapidly evolving questions in genitourinary oncology: the optimal treatment approach for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Series Faculty @BertrandTOMBAL @ChrisSweens1 @jmmrad @drjefstathiou @CaPsurvivorship @LoebStacy @charlesryanmd @AarmstrongDuke @Ecastromarcos @LVM_Walz @piet_ost @Nicola_Fossati @AnthonyMJoshua @Prof_Nick_James @VedangMurthy @AttardLab @Silke_Gillessen @AOmlin Pinging @AmandaNizamMD @scocmem @nataliagandur @gu_onc @tompowles1 @brian_rini @declangmurphy @cdanicas @neerajaiims

How can multidisciplinary involvement improve patient-centered care in hormone-sensitive prostate cancer (HSPC)? Watch Axel Merseburger discuss the importance of communication and knowledge exchange in HSPC management – free and on demand